American Vietnamese Biotech Incorporation Past Earnings Performance
Past criteria checks 0/6
American Vietnamese Biotech Incorporation's earnings have been declining at an average annual rate of -51.5%, while the Medical Equipment industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 20.4% per year.
Key information
-51.5%
Earnings growth rate
-61.2%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -20.4% |
| Return on equity | -6.4% |
| Net Margin | -54.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How American Vietnamese Biotech Incorporation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 179,705 | -98,428 | 112,687 | 0 |
| 31 Mar 24 | 199,114 | 11,748 | 15,627 | 0 |
| 31 Dec 23 | 196,107 | 13,581 | 16,895 | 0 |
| 30 Sep 23 | 209,697 | 11,863 | 16,301 | 0 |
| 30 Jun 23 | 252,811 | 13,046 | 17,124 | 0 |
| 31 Mar 23 | 277,055 | 45,004 | 16,206 | 0 |
| 31 Dec 22 | 281,818 | 53,931 | 15,478 | 0 |
| 30 Sep 22 | 296,027 | 86,360 | 16,241 | 0 |
| 30 Jun 22 | 273,138 | 114,497 | 16,639 | 0 |
| 31 Mar 22 | 232,779 | 87,623 | 15,087 | 0 |
| 31 Dec 21 | 223,843 | 82,240 | 14,028 | 0 |
| 30 Sep 21 | 182,322 | 59,369 | 12,068 | 0 |
| 30 Jun 21 | 140,802 | 36,497 | 10,107 | 0 |
| 31 Mar 21 | 151,117 | 57,277 | 9,233 | 0 |
| 31 Dec 20 | 161,431 | 78,057 | 8,358 | 0 |
| 30 Sep 20 | 310,160 | 177,999 | 10,098 | 0 |
| 30 Jun 20 | 402,892 | 222,303 | 11,124 | 0 |
| 31 Mar 20 | 444,184 | 220,137 | 12,280 | 0 |
| 31 Dec 19 | 487,382 | 219,842 | 11,710 | 0 |
| 30 Sep 19 | 593,630 | 228,969 | 8,085 | 0 |
| 30 Jun 19 | 582,905 | 239,890 | 5,166 | 0 |
| 31 Mar 19 | 535,005 | 242,102 | 3,397 | 0 |
| 31 Dec 18 | 450,796 | 215,098 | 2,901 | 0 |
Quality Earnings: AMV is currently unprofitable.
Growing Profit Margin: AMV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMV is unprofitable, and losses have increased over the past 5 years at a rate of 51.5% per year.
Accelerating Growth: Unable to compare AMV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.4%).
Return on Equity
High ROE: AMV has a negative Return on Equity (-6.36%), as it is currently unprofitable.